Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 12, 2012 - Issue 1
Submit an article Journal homepage
79
Views
66
CrossRef citations to date
0
Altmetric
Research Update

Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland

Marion Bennie Strathclyde Institute for Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK; Information Services Division, NHS National Services Scotland, Edinburgh, EH12 9EB, UK; Strathclyde Institute for Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK; Information Services Division, NHS National Services Scotland, Edinburgh, EH12 9EB, UK
,
Brian Godman Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. [email protected]; Institute for Pharmacological Research ‘Mario Negri’, Via Giuseppe La Masa 19, 20156 Milan, Italy; University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. [email protected]; Institute for Pharmacological Research ‘Mario Negri’, Via Giuseppe La Masa 19, 20156 Milan, Italy; University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK
,
Iain Bishop Information Services Division, NHS National Services Scotland, Edinburgh, EH12 9EB, UK; Information Services Division, NHS National Services Scotland, Edinburgh, EH12 9EB, UK
&
Stephen Campbell Primary Care Research Group, University of Manchester, M13 9PL, UK; Primary Care Research Group, University of Manchester, M13 9PL, UK
Pages 125-130 | Published online: 09 Jan 2014

References

  • Godman B, Shrank W, Andersen M et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilisation: changes seen and global implications. Expert Rev. Pharmacoeconomics Outcomes Res.10(6), 707–722 (2010).
  • Godman B, Shrank W, Andersen M et al. Policies to enhance prescribing efficiency in Europe: findings and future implications. Front. Pharmacol.1(141), 1–16 (2011).
  • Duerden M. Making sense of drug pricing. In: Prescriber Supplement 1–5. John Wiley & Sons Ltd, Chichester, UK (2006).
  • Chaplin S, Duerdin M. When Brands are Best: Brand vs. Generic Prescribing: Prescriber Guide. Wiley Interface Ltd, NJ, USA (2006).
  • McGinn D, Godman B, Lonsdale J et al. Initiatives to enhance the efficiency of statin and proton pump inhibitor prescribing in the UK; impact and implications. Expert Rev. Pharmacoeconomics Outcomes Res.10(1), 73–85 (2010).
  • Kanavos P. Do generics offer significant savings to the UK national health service? Curr. Med. Res. Opin.23, 105–116 (2007).
  • Godman B, Shrank W, Wettermark B et al. Use of generics – a critical cost containment measure for all healthcare professionals in Europe? Pharmaceuticals3, 2470–2494 (2010).
  • Smith PC, York N. Quality incentives: the case of UK general practioners. Health Affairs23, 112–118 (2004).
  • Doran T, Fullwood C, Gravelle H et al. Pay-for-performance programs in family practices in the United Kingdom. N. Engl. J. Med.355, 375–384 (2006).
  • Collins R, Armitage J, Parish S et al. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet361, 2005–2016 (2003).
  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology and the European Association for the Study of Diabetes. Eur. Heart J.28, 88–136 (2007).
  • Godman B, Haycox A, Schwabe U et al. Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies. Pharmacoeconomics26, 91–98 (2008).
  • Norman C, Zarrinkoub R, Hasselström J et al. Potential savings without compromising the quality of care. Int. J. Clin. Pract.63, 1320–1326 (2009).
  • Usher-Smith J, Ramsbottom T, Pearmain H, Kirby M. Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on. Int. J. Clin. Pract.62, 480–484 (2008).
  • Hjemdahl P, Allhammar A, Heaton C et al. SBU should investigate what is an evidencebased and cost-effective use of statins. Läkartidningen32, 1992–1994 (2009).
  • Feely J, Bennett K. Epidemiology and economics of statin use. Ir. Med. J.101, 188–191 (2008).
  • Vončina L, Strizrep T, Godman B et al. Influence of prescribing restrictions compared with other demand side measures to enhance renin–angiotensin prescribing efficiency: implications for other countries. Expert Rev. Pharmacoeconomics Outcomes Res.11, 469–479 (2011).
  • Gustafsson LL, Wettermark B, Godman B et al. The ‘wise list’ – a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin. Pharmacol. Toxicol.108, 224–233 (2011).
  • Moon J, Flett A, Godman B, Grosso A, Wierzbicki A. Getting better value from the NHS drug budget. BMJ342, 30–32 (2011).
  • Wettermark B, Godman B, Jacobsson B, Haaijer-Ruskamp F. Soft regulations in pharmaceutical policymaking – an overview of current approaches and their consequences. Appl. Health Econ. Health Policy7, 137–147 (2009).
  • Duerden M, Miller J, Godman B et al. Centralised guidance – how NICE and SIGN impact on care in the UK. In: Bausteine Für Ein Neues Gesundheitswesen. Klusen N, Straub C (Eds). Nomos Verlagsgesellschaft, Baden-Baden, Germany, 51–61 (2003).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.